What is the equivalent dose of short-acting metoprolol (metoprolol tartrate) to long-acting metoprolol (metoprolol succinate)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Equivalent Dosing of Metoprolol Tartrate and Metoprolol Succinate

A 100-mg metoprolol succinate (extended-release) tablet is considered equivalent to 100 mg of metoprolol tartrate (immediate-release), but the key difference is in dosing frequency: metoprolol tartrate requires twice-daily administration while metoprolol succinate is given once daily. 1

Pharmacokinetic Basis for Equivalency

The equivalency is based on the total daily dose of active metoprolol delivered, not on the salt form itself:

  • A 100-mg metoprolol controlled/extended-release tablet contains 95 mg of metoprolol succinate and is considered to have equivalent activity to 100 mg metoprolol tartrate 1
  • The extended-release formulation disintegrates into individual pellets that release drug at a relatively constant rate over approximately 20 hours, providing even plasma concentrations without the marked peaks and troughs seen with immediate-release formulations 1, 2

Clinical Dosing Conversion

When converting between formulations, use the following approach:

For Heart Failure with Reduced Ejection Fraction (HFrEF):

  • Metoprolol tartrate: Start at 6.25 mg twice daily (12.5 mg total daily dose), titrate to target of 50 mg twice daily (100 mg total daily dose) 3
  • Metoprolol succinate: Start at 25 mg once daily, titrate to target of 200 mg once daily 4, 3

Note the fourfold greater starting dose of metoprolol succinate (25 mg vs 6.25 mg) produces similar hemodynamic and clinical effects as metoprolol tartrate, allowing for more rapid initiation 3

For Hypertension and Other Indications:

  • Metoprolol tartrate: 25-100 mg twice daily (50-200 mg total daily dose) 5
  • Metoprolol succinate: 50-200 mg once daily 5

The total daily dose remains equivalent between formulations 1, 6

Key Clinical Differences Beyond Dosing

While the total daily doses are equivalent, important pharmacodynamic differences exist:

  • Once-daily metoprolol succinate 12.5-200 mg produces even plasma concentrations over 24 hours, leading to consistent beta1-blockade without peaks and troughs 2
  • Both formulations produce similar hemodynamic effects acutely and chronically, with parallel changes in cardiac index, systemic vascular resistance, and stroke volume index 3
  • At 200 mg daily dosing, the extended-release preparation may provide superior exercise tolerance over 24 hours compared to conventional tablets given as 100 mg twice daily 6

Common Pitfalls to Avoid

  • Do not assume you can simply give half the daily dose of metoprolol succinate twice daily—the formulations are designed for different dosing frequencies and the extended-release mechanism requires once-daily administration 1, 2
  • When initiating therapy in heart failure patients, metoprolol succinate allows for a higher starting dose (25 mg vs 6.25 mg) with similar tolerability, potentially offering advantages in treatment initiation 3
  • Metoprolol tartrate requires twice-daily dosing to maintain adequate beta-blockade over 24 hours in most patients, as once-daily conventional metoprolol provides inferior 24-hour coverage compared to atenolol 7

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.